Literature DB >> 15629836

Vision-related quality of life in patients with bilateral severe age-related macular degeneration.

Mark T Cahill1, Avie D Banks, Sandra S Stinnett, Cynthia A Toth.   

Abstract

PURPOSE: To determine the quality of life (QOL) of patients with bilateral severe age-related macular degeneration (AMD) before macular translocation with 360 degrees peripheral retinectomy.
DESIGN: Prospective, consecutive, noncomparative case series.
METHODS: An observational study assessed vision-related and general health QOL using the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and the Medical Outcomes Study 12-item short form (SF-12) surveys, respectively. Mean QOL scores were correlated with patient age, duration of vision loss, and visual function. Mean QOL scores in study patients were compared with mean QOL scores in groups of patients with low vision, patients with AMD of varying severity, and reference populations. MAIN OUTCOME MEASURES: National Eye Institute VFQ-25 and SF-12 QOL scores.
RESULTS: Seventy patients with a mean age of 76.4 years were studied. Mean distance visual acuity (VA) was 62.4 (Early Treatment Diabetic Retinopathy Study letters), mean near VA was 0.81 (logarithm of the minimum angle of resolution), and mean reading speed was 74.9 words per minute. Important NEI VFQ-25 quality of vision subscales (general vision, difficulty with distance tasks, difficulty with near tasks) and vision-specific subscales (dependency, role difficulties, mental health, social function limitations) tended to correlate negatively with increasing patient age and duration of vision loss, but correlated positively with better VA and reading speed. The mean QOL scores for these important quality of vision and vision-specific subscales were significantly worse than or similar to mean scores in patients with low vision, and significantly worse than scores in patients with AMD of varying severity and a reference population. The mean SF-12 physical composite score in study patients was similar to that seen in patients with AMD of varying severity, but significantly higher than that in patients with low vision and a reference population. The SF-12 mental composite score in study patients was similar to those of all 3 comparison groups.
CONCLUSIONS: Patients with bilateral severe AMD have vision-related QOL similar to that of patients with low vision but significantly worse than those of patients with AMD of varying severity and persons without eye disease. This inability to perform vision-related daily tasks is not related to general health problems.

Entities:  

Mesh:

Year:  2005        PMID: 15629836     DOI: 10.1016/j.ophtha.2004.06.036

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  52 in total

1.  Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration--a report of 1 year results.

Authors:  Matthias Lüke; Focke Ziemssen; Karl Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-09       Impact factor: 3.117

2.  Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease.

Authors:  Ujwala S Saboo; Francisco Amparo; Tulio B Abud; Debra A Schaumberg; Reza Dana
Journal:  Ophthalmology       Date:  2015-05-20       Impact factor: 12.079

3.  Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Ahmed A Salama; Marina E Israel; Ghada A Elhawary; Ahmed E Radwan; Mohamed M Elgayar; Tamer M El Nakhal; Islam T Elkhateb; Heba A Hashem; Doha K Embaby; Amira A Elabd; Reem K Elwy; Magdi S Yacoub; Hamdy Salem; Mohamed Abdel-Baqy; Ahmad Kassem
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

4.  Health-related quality of life among people aged ≥65 years with self-reported visual impairment: findings from the 2006-2010 behavioral risk factor surveillance system.

Authors:  John E Crews; Chiu-Fang Chou; Xinzhi Zhang; Matthew M Zack; Jinan B Saaddine
Journal:  Ophthalmic Epidemiol       Date:  2014-06-23       Impact factor: 1.648

5.  The Association of Health-Related Quality of Life with Severity of Visual Impairment among People Aged 40-64 Years: Findings from the 2006-2010 Behavioral Risk Factor Surveillance System.

Authors:  John E Crews; Chiu-Fang Chou; Matthew M Zack; Xinzhi Zhang; Kai McKeever Bullard; Alan R Morse; Jinan B Saaddine
Journal:  Ophthalmic Epidemiol       Date:  2016-05-09       Impact factor: 1.648

6.  Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study.

Authors:  Rohit Varma; Athena W P Foong; Mei-Ying Lai; Farzana Choudhury; Ronald Klein; Stanley P Azen
Journal:  Am J Ophthalmol       Date:  2010-05       Impact factor: 5.258

7.  Caregiver perceptions about the impact of caring for patients with wet age-related macular degeneration.

Authors:  M Vukicevic; J Heraghty; R Cummins; B Gopinath; P Mitchell
Journal:  Eye (Lond)       Date:  2015-11-27       Impact factor: 3.775

8.  Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

Authors:  Matthias Lüke; Focke Ziemssen; Michael Völker; Elke Altpeter; Julia Beutel; Dorothea Besch; Karl Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-12       Impact factor: 3.117

9.  Visual impairment and quality of life: gender differences in the elderly in Cuenca, Spain.

Authors:  J J Navarro Esteban; M Solera Martínez; P García Navalón; O Piñar Serrano; J R Cerrillo Patiño; M E Calle Purón; V Martínez-Vizcaíno
Journal:  Qual Life Res       Date:  2007-11-17       Impact factor: 4.147

10.  The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration.

Authors:  Keith Evans; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Clin Ophthalmol       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.